Original language | English |
---|---|
Pages (from-to) | 220-220 |
Journal | ONCOLOGY RESEARCH AND TREATMENT |
Volume | 39 |
Publication status | Published - Oct 2016 |
Impact of the Indoleamine 2,3-dioxygenase (IDO) system and its metabolites on molecular response to Nilotinib therapy in early Chronic Phase Chronic Myelogenous Leukemia (CML-CP)
S. Sopper, S. Mustjoki, G. Gastl, Z. Trajanoski, F. Giles, A. Hochhaus, J. Janssen, S. Geissler, D. Fuchs, D. Wolf
Research output: Contribution to journal › Article › Academic › peer-review